SCHEMBL9212971

SCHEMBL9212971

COC(=O)CCCC(=O)c1ccc(O)c(CCC(=O)OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
CYP2C19 P33261 1/20 0.44
CKS1B P61024 1/20 0.44
SKP2 Q13309 1/20 0.44
HIF1A Q16665 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PDE4B Q07343 1/20 0.43
TSHR P16473 2/20 0.43
NPC1 O15118 3/20 0.41
RAB9A P51151 2/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9120986 0.86 CYP4F2 (0.47) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL9214073 0.85 CA12 (0.54) PDE4BTSHRNPC1RAB9APOLB
SCHEMBL8416607 0.84 CTNNB1 (0.47) ALDH1A1PDE4BTSHRMTNR1AMTNR1B
SCHEMBL9213274 0.80 PDE4B (0.49) ALDH1A1HPGDHSD17B10PDE4BNPC1
SCHEMBL27383378 0.77 AMY1A (0.46) ALDH1A1HPGDTP53CYP1A2CYP3A4
SCHEMBL9120806 0.77 CYP4F2 (0.49) ALDH1A1HPGDMEN1KMT2AHTT
SCHEMBL12658569 0.77 HSD17B3 (0.52) ALDH1A1MEN1KMT2AHTT
SCHEMBL10387695 0.76 ALDH1A1 (0.48) ALDH1A1HPGDTP53CYP1A2CYP3A4
SCHEMBL3136286 0.76 MEN1 (0.50) HPGDCYP1A2CYP3A4CYP2C9ALOX15
SCHEMBL9128626 0.76 ALDH1A1 (0.55) ALDH1A1HPGDTP53CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0549621-B1 NEW LEUKOTRIENE-B4 ANTAGONISTS, PROCESS FOR PRODUCING THE SAME AND THEIR USE AS MEDICINAL DRUGS SCHERING AG (DE) 1995-09-27 EP disclosed
US-5352701-A Leukotriene-B4 antagonist compounds and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1994-10-04 US disclosed
EP-0549621-A1 NEW LEUKOTRIENE-B 4? ANTAGONISTS, PROCESS FOR PRODUCING THE SAME AND THEIR USE AS MEDICINAL DRUGS. SCHERING AG (DE) 1993-07-07 EP disclosed
WO-1992004311-A1 NEW LEUKOTRIENE-B4 ANTAGONISTS, PROCESS FOR PRODUCING THE SAME AND THEIR USE AS MEDICINAL DRUGS SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1992-03-19 WO disclosed